SCHEMBL25027490

SCHEMBL25027490

Cc1ncc2[nH]c(=O)n(-c3ccc(Oc4cccc5c4C4(CC4)CO5)nc3)c2n1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30793996 1.00 GSK3B (0.30) GSK3B
SCHEMBL25025758 0.91 MMP13 (0.33) GSK3B
SCHEMBL30193980 0.91 MMP13 (0.33) GSK3B
SCHEMBL30193778 0.87
SCHEMBL25027704 0.87
SCHEMBL23926963 0.86 TNKS (0.31)
SCHEMBL30079226 0.86 TNKS (0.31)
SCHEMBL25027812 0.85 MMP13 (0.31)
SCHEMBL23927024 0.85 GABRP (0.36)
SCHEMBL30193511 0.85 MMP13 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117751119-A Potassium channel modulators 奥蒂福尼疗法有限公司 2024-03-22 CN claimed
CN-117751119-A Potassium channel modulators 奥蒂福尼疗法有限公司 2024-03-22 CN disclosed
WO-2023017263-A1 POTASSIUM CHANNEL MODULATORS AUTIFONY THERAPEUTICS LIMITED (GB) 2023-02-16 WO disclosed